NYSE: EMREmerson Electric

    Emerson Electric Q4 FY2026 Results: Net Income $744 Million on Revenue of $5.2 Billion

    • US stocks
    • Earnings
    • Industrials
    Aerial view of a container terminal with stacked containers, yellow cranes and road lanes
    chuttersnap chuttersnap, via Wikimedia Commons (CC0). Illustrative image.

    Emerson Electric (NYSE: EMR) reported results for the fourth quarter and fiscal year 2026, with GAAP net sales of $5.20 billion and GAAP net earnings to common stockholders of $744.0 million for the quarter, it said on 4 Nov 2026. GAAP diluted EPS was $1.33; adjusted EPS, a company-defined non-GAAP measure, was $1.86.

    Key highlights

    • Net sales (GAAP): $5.20 billion, up 7.1% YoY
    • Diluted EPS (GAAP): $1.33, up 23.1% YoY
    • Adjusted EPS (company-defined, non-GAAP): $1.86, up 15% YoY
    • Underlying orders (company measure): up 14%
    • Quarterly dividend: $0.595 per share, up 7%

    Summary

    Consolidated (GAAP) $ million
    ParticularsQ4 FY2026Q4 FY2025YoY
    Revenue5,201.04,855.0+7.1%
    744.0609.0+22.2%
    Diluted EPS ($)1.331.08+23.1%

    Figures are in $ million except EPS; YoY compares with Q4 FY2025. Q4 FY2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.

    The table compares the quarter with the same quarter a year earlier. Net sales rose 7.1%, from $4.86 billion to $5.20 billion, and diluted EPS rose 23.1%, from $1.08 to $1.33. GAAP net income was 14.3% of revenue, against 12.5% a year earlier, 1.8 percentage points higher.

    The year-ago figures are the release's own comparatives, and the table gives no quarter-on-quarter comparison.

    Adjusted EPS excludes items the company names

    Adjusted EPS is a company-defined non-GAAP measure. It excludes intangibles amortization, restructuring and related costs, first year purchase accounting items, transaction costs, the pension mark-to-market adjustment, discrete taxes, and certain gains, losses or impairments. In the quarter it also excluded IEEPA tariff refunds net of a charitable trust contribution, a $9 million item. On that adjusted basis, adjusted segment EBITA was $1.51 billion, a 29.1% margin.

    Segment sales rose in all three groups

    Software & Systems sales were $1.71 billion, up 14%, Intelligent Devices sales were $2.92 billion, up 5%, and Safety & Productivity sales were $573.0 million, up 2%. Pretax earnings were $997 million, a 19.2% margin, against $760 million and a 15.6% margin a year earlier.

    The company said underlying orders rose 14%, excluding AspenTech, and that demand was broad-based across business groups and regions. CEO Lal Karsanbhai attributed the orders growth to long-cycle project activity in the company's growth verticals.

    The 2027 outlook is approximate

    The company said its 2027 guidance figures are approximate. For 2027 it expects GAAP EPS of about $5.70 and adjusted EPS of about $7.25, with net sales and underlying sales growth of about 5% each. It expects free cash flow of $3.8 billion to $3.9 billion, and says the outlook assumes about $2.5 billion of share repurchases and about $1.3 billion of dividends.

    Inference

    Diluted average shares were 559.7 million, against 565.5 million a year earlier. In fiscal 2026 the company spent $1,000 million on purchases of common stock and paid $1,244 million in dividends.

    The company declared a quarterly dividend of $0.595 per share, payable 10 Dec 2026 to stockholders of record on 13 Nov 2026. The release does not state fourth-quarter share repurchases, and the next dated step is the 10 Dec 2026 dividend payment.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts